SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is currently at the center of investor anxiety as renewed geopolitical tensions in the Middle East and concerns over trade routes spark volatility. Community members are actively debating the potential impact of these disruptions on tech valuations and market stability, while many remain focused on whether upcoming earnings and economic data will sustain current momentum despite the geopolitical noise.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility and heavy retail attention as investors react to sharp, aggressive price swings and large-scale liquidations tied to South Korea's KOSPI index. The community is actively debating the impact of upcoming SK Hynix's US listing, the mechanics of leveraged ETFs, and whether current dips represent a buying opportunity or a deeper structural risk.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is facing heightened volatility as market participants weigh renewed geopolitical tensions in the Middle East and concerns over energy infrastructure against the momentum of the ongoing AI-led bull market. The community remains deeply divided, with many traders debating whether recent price dips offer a strategic buying opportunity or signal a broader shift in sentiment ahead of critical inflation data and earnings announcements.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix shares are in focus as the company makes its highly anticipated U.S. debut on the Nasdaq, with investors closely watching for impact on the broader semiconductor and memory sector. The community is actively debating the ADR pricing relative to its Korean listing, debating the potential for long-term AI-driven growth versus short-term institutional profit-taking, and comparing its valuation to domestic industry peers like Micron.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market discussions as investors navigate a complex environment defined by geopolitical tensions in the Middle East and a significant rotation of capital away from high-flying technology stocks into value-oriented sectors. Community sentiment remains polarized, with many traders debating the sustainability of current all-time highs amid concerns over economic policy, potential Federal Reserve rate adjustments, and the broader impact of an ongoing sector rotation.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is surging as investors pivot to the drone and autonomous defense sectors, viewing the company as a key pick-and-shovel play for high-density, NDAA-compliant battery technology. The community is actively discussing the company's manufacturing-light strategy and potential for increased contract awards, with many traders framing recent volatility as a strategic entry point ahead of long-term sector growth.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery and Paramount Skydance are trending as investors await the April 23 shareholder vote to approve the $110 billion merger, which faces scrutiny over executive compensation packages and potential regulatory hurdles. The community is actively debating the deal's long-term impact on industry consolidation, the viability of the combined entity's debt reduction strategy, and whether this move will effectively allow the new conglomerate to compete with major streaming incumbents.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending due to intense speculation regarding a potential buyout from major oncology players, particularly Merck, as investors look for catalysts ahead of key clinical data readouts. While community sentiment is heavily polarized between bullish supporters citing institutional accumulation and the potential for a curative AML platform, and skeptical traders warning against buyout rumors and trial protocol uncertainties, the conversation remains tightly focused on the upcoming unblinding of the REGAL phase 3 trial.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Public Cloud and Private Cloud. The Public Cloud segment is a services-centric, capital-light model providing value-added cloud solutions through managed services, Elastic Engineering and professional services offerings for customer environments hosted on the AWS, Microsoft Azure and Google Cloud public cloud platforms. The Private Cloud segment is a technology-forward, capital-intensive model providing managed service offerings for customer environments hosted in data centers as well as in those owned by customers or by third parties such as colocation providers. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is seeing significant momentum as investors digest a major pivot toward high-margin Enterprise AI infrastructure, highlighted by strategic agreements with industry giants like AMD and Palantir. While the community is actively debating the potential dilutive impact of a recently announced at-the-market offering and recent revenue guidance adjustments, sentiment remains split between those focused on the long-term AI growth narrative and those concerned about the company's debt profile and potential share dilution.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing high community engagement as investors debate the impact of the company's recent White House visibility and potential federal defense contracts versus the stock's recent downward price pressure. While some traders express frustration with the current volatility, many long-term holders view the price drop as an accumulation opportunity, betting that the company's neutral-atom quantum technology will eventually align with its fundamental growth potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top 3 Health Care Stocks You'll Regret Missing In Q2

Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold, according to Benzinga Pro. iRhythm, Procept Biorobotics, Anbio Biotechnology among lowest RSI values.read more...

Anbio Biotechnology (NASDAQ:NNNN) Shares Up 11.6% - Time to Buy?

Anbio Biotechnology (NASDAQ:NNNN) Trading Up 11.6% - What's Next...

Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down   - Should You Sell?

Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down - Should You Sell...

Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.5% - Here's What Happened

Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.5% - Here's Why...

Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio

Anbio Biotechnology reported strong 2025 results with sales of $8.65M. The company is diversifying away from COVID products.read more...

Anbio Biotechnology (NASDAQ:NNNN) Shares Up 4.4%  - Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN) Trading Up 4.4% - Still a Buy...

Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up - Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up - What's Next...

Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 5.6% - Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN) Trading 5.6% Higher - Here's What Happened...

Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up   - Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up - Still a Buy...

Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down   - Time to Sell?

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.

Anbio Biotechnology - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$9.39
Prev Close	$11.15
Open	$10.94
Dividend Yield	0.00%
50-Day Moving Average	$22.29
Beta	0.43
Avg. Volume	49,833.99
PE Ratio	57.36

52-Week High	$55.65
52-Week Low	$8.30
Market Capitalization	$1.35B
EPS (Annual)	$0.1646
Price to Book	11.64
Revenue Per Employee	$361,431.00

Feed

News

Sentiment

Fundamentals

Info

NNNNAnbio Biotechnology

Latest NNNN News